Jennison Associates LLC Buys 238,114 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Jennison Associates LLC increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 26.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,148,755 shares of the company's stock after buying an additional 238,114 shares during the period. Jennison Associates LLC owned 1.25% of Acadia Healthcare worth $89,327,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in Acadia Healthcare by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 8,831,131 shares of the company's stock valued at $620,917,000 after purchasing an additional 26,379 shares during the period. Wellington Management Group LLP lifted its position in Acadia Healthcare by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company's stock valued at $529,991,000 after purchasing an additional 152,783 shares during the period. William Blair Investment Management LLC lifted its position in Acadia Healthcare by 0.3% during the 3rd quarter. William Blair Investment Management LLC now owns 3,058,916 shares of the company's stock valued at $215,072,000 after purchasing an additional 10,062 shares during the period. Bank of New York Mellon Corp lifted its position in Acadia Healthcare by 1.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,258,459 shares of the company's stock valued at $88,482,000 after purchasing an additional 13,765 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in Acadia Healthcare by 4.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 996,704 shares of the company's stock valued at $70,078,000 after purchasing an additional 38,664 shares during the period.

Analysts Set New Price Targets

A number of brokerages have recently commented on ACHC. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Mizuho upped their price target on Acadia Healthcare from $77.00 to $84.00 and gave the company a "neutral" rating in a research note on Wednesday, March 6th. Barclays began coverage on Acadia Healthcare in a research note on Wednesday, March 6th. They issued an "overweight" rating and a $100.00 price target for the company. Stephens raised Acadia Healthcare from an "equal weight" rating to an "overweight" rating and set a $92.00 price target for the company in a research note on Friday, January 5th. Finally, UBS Group upped their price target on Acadia Healthcare from $88.00 to $102.00 and gave the company a "buy" rating in a research note on Wednesday, February 28th. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $94.75.

Acadia Healthcare Stock Up 0.7 %

NASDAQ ACHC traded up $0.48 during trading hours on Tuesday, reaching $70.74. 539,126 shares of the company's stock were exchanged, compared to its average volume of 561,652. The company's 50-day moving average is $78.91 and its two-hundred day moving average is $77.71. Acadia Healthcare Company, Inc. has a one year low of $66.49 and a one year high of $87.77. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. The company has a market capitalization of $6.54 billion, a price-to-earnings ratio of -281.03, a price-to-earnings-growth ratio of 2.07 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, topping analysts' consensus estimates of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The firm had revenue of $742.80 million during the quarter, compared to the consensus estimate of $727.60 million. During the same quarter in the prior year, the firm posted $0.70 EPS. The business's revenue was up 10.0% on a year-over-year basis. On average, analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current fiscal year.

Insiders Place Their Bets

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the company's stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares of the company's stock, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 2.80% of the company's stock.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.